Results 61 to 70 of about 7,120 (170)
Emerging Medications in Facial Nerve Recovery: A Systematic Review and Meta‐Analysis
Abstract Objective To systematically review the literature for medical therapies that promote facial nerve regeneration and recovery. Data Sources PubMed/Medline, Embase, and SCOPUS databases were searched for English‐language studies published from inception through May 2025.
Kimberly Chan +5 more
wiley +1 more source
Background Sporadic vestibular schwannoma, a benign tumor affecting the vestibulocochlear nerve, poses significant health challenges due to its impact on hearing, balance, and facial nerve function.
Yuyang Liu +9 more
doaj +1 more source
TANC1::HTRA1 fusion in schwannomas
Brain Pathology, Volume 36, Issue 5, September 2026.
Ilay Caliskan +3 more
wiley +1 more source
First case of 18F-choline uptake in acoustic schwannoma after stereotactic radiotherapy
A 69-year-old male patient, with bilateral hypoacusia and tinnitus, had a diagnosis of left vestibular schwannoma with synchronous meningioma on the left frontal lobe.
Demetrio Arico +4 more
doaj +3 more sources
This study examined the association between hearing loss in sporadic vestibular schwannoma patients and the proteome of perilymph (PL), cerebrospinal fluid (CSF), and vestibular schwannoma.
Jesper Edvardsson Rasmussen +4 more
doaj +1 more source
Tumor-to-tumor metastasis is a well-recognized phenomenon. However, cerebellopontine angle tumor, especially vestibular schwannoma, is a rare location of metastasis, with only six cases being reported previously in English-language literature reviews. We
Boon-Kee Lua +2 more
doaj +1 more source
Objective: Compare the risk of developing Vestibular schwannoma in patients prescribed Hormone Therapy (HT). Methods: We performed a systematic review in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA), the
Maria Vitória Graça Couto de Campos Amaral +1 more
doaj +1 more source
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Objective To summarize the surgical experience of retrosigmoid approach vestibular schwannoma resection, and to identify influencing factors for postoperative hearing preservation.
CHAI Qi +5 more
doaj +1 more source
Objective ‒ to improve the morphological diagnosis of vestibular schwannoma (VS) based on the assessment of structural characteristics and features of stromal and perenchymal changes. Materials and methods.
O.Yu. Malysheva +5 more
doaj +1 more source

